Wenming Li
- Pharmacology top 2%
- Cholinesterase and Neurodegenerative Diseases 11
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 6
-
- Neuroscience and Neuropharmacology Research 7
- Physiology top 5%
- Alzheimer's disease research and treatments 13
- Cancer Research top 10%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
-
- Autophagy in Disease and Therapy 9
-
- Endoplasmic Reticulum Stress and Disease 8
- Journals
- Journal of Biological Chemistry (2 papers)Nature Communications (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wenming Li
53 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 111
- Pharmacology 389
- Neurology 177
- Cellular and Molecular Neuroscience 323
- Physiology 419
- Cancer Research 210
Countries citing papers authored by Wenming Li
This map shows the geographic impact of Wenming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenming Li more than expected).
Fields of papers citing papers by Wenming Li
This network shows the impact of papers produced by Wenming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenming Li. The network helps show where Wenming Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2022 | 11 | |
| 4 | 2022 | 12 | |
| 5 | 2021 | 17 | |
| 6 | 2020 | 37 | |
| 7 | 2019 | 1 | |
| 8 | 2018 | 6 | |
| 9 | 2018 | 29 | |
| 10 | 2017 | 56 | |
| 11 | 2017 | 12 | |
| 12 | 2015 | 63 | |
| 13 | 2013 | 60 | |
| 14 | 2012 | 19 | |
| 15 | 2012 | 90 | |
| 16 | 2012 | 54 | |
| 17 | 2011 | 32 | |
| 18 | 2010 | 7 | |
| 19 | 2007 | 14 | |
| 20 | 2007 | 40 |
About Wenming Li
Wenming Li is a scholar working on Cancer Research, Pharmacology and Physiology, having authored 54 papers that have together received 1.8k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (13 papers), Cholinesterase and Neurodegenerative Diseases (11 papers), Autophagy in Disease and Therapy (9 papers), Endoplasmic Reticulum Stress and Disease (8 papers), Neuroscience and Neuropharmacology Research (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers), MicroRNA in disease regulation (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Pharmacology (389 citations), Neurology (177 citations) and Cellular and Molecular Neuroscience (323 citations). Wenming Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zixu Mao, Yifan Han, Qian Yang, Rongbiao Pi, Juan Dou, Hua She, Nelson T.K. Lee, Yuan‐Ping Pang, Jinqiu Zhu and Peiqing Liu. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.